Drug discovery in HD: Oxford spinoff’s mass spectrometry approach scores fresh funding

Published

February 18, 2020

Drug discovery in HD: Oxford spinoff’s mass spectrometry approach scores fresh funding

The technology used to detect explosives at airports — mass spectrometry — is being piloted as an engine for drug discovery…

MORERelated News
Introducing Fierce Biotech’s 2024 Fierce 15 – OMass Therapeutics
What makes OMass fierce: You can’t fault OMass for its ambition. The company may still be in preclinical development, but it...
Dame Carol Robinson to receive Lifetime Achievement Award for groundbreaking protein analysis work
The European Patent Office (EPO) has announced that Dame Carol Robinson, Professor of Chemistry at the University of Oxford, will receive...
5 Pharmaceutical Companies in the UK to Know
OMass uses high-resolution mass spectrometry to study protein assemblies and discover new medicines. Its spectrometry platform, called OdyssION, enables better visualization...